Copyright
©The Author(s) 2016.
World J Hepatol. Mar 18, 2016; 8(8): 395-400
Published online Mar 18, 2016. doi: 10.4254/wjh.v8.i8.395
Published online Mar 18, 2016. doi: 10.4254/wjh.v8.i8.395
Table 1 Classification of iron overload and hemochromatosis
| Genetic iron overload (primary) |
| Type 1 HFE-associated hemochromatosis |
| C282Y homoyzygosity |
| C282Y/H63D compound heterozygosity |
| Type 2 juvenile hemochromatosis |
| 2A hemojuvelin mutations |
| 2B hepcidin mutations |
| Type 3 TfR2-related hemochromatosis |
| Transferrin receptor 2 |
| Type 4 ferroportin disease |
| Loss of function mutations, also called type 4A or "M" |
| Hepcidin resistance mutations, also called type 4B or "H" |
| Aceruloplasminemia |
| Ceruloplasmin mutations |
| A(hypo)transferrinemia |
| Acquired iron overload (secondary) |
| Ineffective erythropoiesis |
| Thalassemia major |
| Sideroblastic anemia |
| Chronic hemolytic anemia |
| Dietary iron overload (African) |
| Parenteral iron overload (including transfusional overload) |
- Citation: Sivakumar M, Powell LW. Management of human factors engineering-associated hemochromatosis: A 2015 update. World J Hepatol 2016; 8(8): 395-400
- URL: https://www.wjgnet.com/1948-5182/full/v8/i8/395.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i8.395
